Asker Clinches SEK 26.8 Billion IPO on Nasdaq Stockholm
Deal News | Mar 27, 2025 | White & Case
Global law firm White & Case LLP successfully advised Nalka and its portfolio company, Asker Healthcare Group AB, on Asker's significant initial public offering (IPO) valued at SEK 26.8 billion, with trading commencing on Nasdaq Stockholm on March 27, 2025. This monumental transaction underscores the robustness of the Nordic capital markets and investor confidence in the area. The White & Case team leader highlighted the firm's unique platform that harmonizes local and U.S. expertise in guiding high-profile listings. In collaboration with Nalka, an investment powerhouse with a focus on small-to-medium businesses in the Nordic and DACH regions, Asker has poised itself as a leading European provider of medical products, operating across 17 countries. This IPO marks a key milestone in their strategic evolution.
Sectors
- Healthcare
- Capital Markets
- Legal Services
Geography
- Sweden – Asker Healthcare Group, the target company, is headquartered in Sweden and listed on Nasdaq Stockholm.
- Nordic Region – Both the investment firm Nalka and Asker operate extensively within the Nordic region, impacting the regional capital markets.
- Europe – Asker's operations across 17 European countries underscore the company's continental reach in the healthcare sector.
Industry
- Healthcare – Asker Healthcare Group is a leading provider of medical products and solutions, catering to the European healthcare sector.
- Capital Markets – The IPO and listing on Nasdaq Stockholm are key events in the capital markets industry, showcasing the activity in Nordic financial markets.
- Legal Services – White & Case's advisory role in this transaction highlights the legal services sector's involvement in high-profile IPO deals.
Financials
- SEK 26.8 billion – The total value of Asker Healthcare Group AB's initial public offering on Nasdaq Stockholm.
- SEK 70 – The IPO price per share of Asker Healthcare Group AB.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Asker Healthcare Group AB | Target | Company | A leading provider of medical products in Europe, operating in 17 countries with over 4,000 employees. |
| Nalka | Selling Company | Company | An investment firm that focuses on small and medium-sized businesses in the Nordic and DACH regions. |
| White & Case LLP | Legal Advisor | Company | A global law firm that advised Asker on its IPO, emphasizing its strength in cross-practice offerings. |